✦ LIBER ✦

Altus using P 450 for making drug metabolites and optimizing drug leads

Book ID: 104384333
Publisher: Elsevier Science
Year: 2003
Weight: 31 KB
Volume: 2003
Category: Article
ISSN: 1351-4180
DOI: 10.1016/s1351-4180(03)00408-2

No coin nor oath required. For personal study only.

✦ Synopsis

Biotech likely to be primary driver of innovation in the chemical industry

A new industrial revolution is taking place as biotechnology becomes an increasingly important catalyst for innovation in the chemical industry. According to one speaker at a recent briefing in New York on industrial biotechnology, "The Third Wave in Biotechnology", biotech is now the key driver in the chemical industry for the next 10 years. The effect of biotech is expected to be substantial, in particular in fine chemicals and some speciality chemicals areas. Around 20%, or $280 bn, of the entire chemicals market of $1400 bn in 2010 could be affected by biotech. Biotechnology has the potential to represent 60% of fine chemicals sales in 2010 (or $90 M), 10-15% of polymer sales ($370 M) and 10-15% of bulk chemical sales ($380 M). With petroleum feedstocks increasing in price and subsidies for renewable resources, there is a strong incentive to develop green processes. 2002 was also a watershed year for biotechnology on the legislative front.

📜 SIMILAR VOLUMES

Chromatographic Determination of Drugs a

Chromatographic Determination of Drugs and Their Metabolites for Phenotyping Cytochrome P-450 Isoenzymes

✍ G. V. Ramenskaya 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 98 KB

A Panel of Cytochrome P450 BM3 Variants

A Panel of Cytochrome P450 BM3 Variants to Produce Drug Metabolites and Diversify Lead Compounds

✍ Andrew M. Sawayama; Michael M. Y. Chen; Palaniappan Kulanthaivel; Ming-Shang Kuo 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 251 KB

## Abstract Herein we demonstrate that a small panel of variants of cytochrome P450 BM3 from __Bacillus megaterium__ covers the breadth of reactivity of human P450s by producing 12 of 13 mammalian metabolites for two marketed drugs, verapamil and astemizole, and one research compound. The most acti

A Diversified Library of Bacterial and F

A Diversified Library of Bacterial and Fungal Bifunctional Cytochrome P450 Enzymes for Drug Metabolite Synthesis

✍ Roland Weis; Margit Winkler; Matthias Schittmayer; Spiros Kambourakis; Mandy Vin 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 177 KB

Preparative synthesis of drug metabolite

Preparative synthesis of drug metabolites using human cytochrome P450s 3A4, 2C9 and 1A2 with NADPH-P450 reductase expressed inEscherichia coli

✍ Robert B. Vail; Michael J. Homann; Imad Hanna; Aleksey Zaks 📂 Article 📅 2005 🏛 Springer-Verlag 🌐 English ⚖ 296 KB

ChemInform Abstract: Novel Hierarchical

ChemInform Abstract: Novel Hierarchical Classification and Visualization Method for Multiobjective Optimization of Drug Properties: Application to Structure—Activity Relationship Analysis of Cytochrome P450 Metabolism.

✍ Fumiyoshi Yamashita; Hideto Hara; Takayuki Ito; Mitsuru Hashida 📂 Article 📅 2008 🏛 John Wiley and Sons ⚖ 11 KB 👁 1 views

## Abstract ChemInform is a weekly Abstracting Service, delivering concise information at a glance that was extracted from about 200 leading journals. To access a ChemInform Abstract of an article which was published elsewhere, please select a “Full Text” option. The original article is trackable v

Studies on the Interactions between Drug

Studies on the Interactions between Drugs and Estrogen: Analytical Method for Prediction System of Gynecomastia Induced by Drugs on the Inhibitory Metabolism of Estradiol Using Escherichia coli Coexpressing Human CYP3A4 with Human NADPH-Cytochrome P450 Reductase

✍ Takashi Satoh; Ken-ichi Fujita; Haruka Munakata; Shinji Itoh; Katsunori Nakamura 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 94 KB

To establish a prediction system for drug-induced gynecomastia in clinical fields, a model reaction system was developed to explain numerically this side effect. The principle is based on the assumption that 50% inhibition concentration (IC 50 ) of drugs on the in vitro metabolism of estradiol (E2)